Current and historical daily PE Ratio for RSMDF (
ResMed Inc
) from 2014 to Apr 25 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. ResMed stock (RSMDF) PE ratio as of Apr 25 2024 is 30.38.
More Details
ResMed Inc (RSMDF) PE Ratio (TTM) Chart
ResMed Inc (RSMDF) PE Ratio (TTM) Historical Data
View and export this data going back to 2014. Start your Free Trial
Total 1213
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| ResMed PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-04-25 | 29.3 | 2024-02-21 | 31.5 |
| 2024-04-24 | 29.3 | 2024-02-20 | 31.5 |
| 2024-04-23 | 29.3 | 2024-02-16 | 31.5 |
| 2024-04-22 | 29.3 | 2024-02-15 | 31.5 |
| 2024-04-19 | 29.3 | 2024-02-14 | 31.5 |
| 2024-04-18 | 29.3 | 2024-02-13 | 31.5 |
| 2024-04-17 | 29.3 | 2024-02-12 | 31.5 |
| 2024-04-16 | 31.5 | 2024-02-09 | 31.5 |
| 2024-04-15 | 31.5 | 2024-02-08 | 31.5 |
| 2024-04-12 | 31.5 | 2024-02-07 | 31.5 |
| 2024-04-11 | 31.5 | 2024-02-06 | 31.5 |
| 2024-04-10 | 31.5 | 2024-02-05 | 31.5 |
| 2024-04-09 | 31.5 | 2024-02-02 | 31.5 |
| 2024-04-08 | 31.5 | 2024-02-01 | 31.5 |
| 2024-04-05 | 31.5 | 2024-01-31 | 31.7 |
| 2024-04-04 | 31.5 | 2024-01-30 | 31.7 |
| 2024-04-03 | 31.5 | 2024-01-29 | 31.7 |
| 2024-04-02 | 31.5 | 2024-01-26 | 31.7 |
| 2024-04-01 | 31.5 | 2024-01-25 | 30.6 |
| 2024-03-28 | 31.5 | 2024-01-24 | 26.8 |
| 2024-03-27 | 31.5 | 2024-01-23 | 26.8 |
| 2024-03-26 | 31.5 | 2024-01-22 | 26.8 |
| 2024-03-25 | 31.5 | 2024-01-19 | 26.8 |
| 2024-03-22 | 31.5 | 2024-01-18 | 26.8 |
| 2024-03-21 | 31.5 | 2024-01-17 | 26.8 |
| 2024-03-20 | 31.5 | 2024-01-16 | 26.8 |
| 2024-03-19 | 31.5 | 2024-01-12 | 26.8 |
| 2024-03-18 | 31.5 | 2024-01-11 | 26.8 |
| 2024-03-15 | 31.5 | 2024-01-10 | 26.8 |
| 2024-03-14 | 31.5 | 2024-01-09 | 26.8 |
| 2024-03-13 | 31.5 | 2024-01-08 | 26.8 |
| 2024-03-12 | 31.5 | 2024-01-05 | 26.8 |
| 2024-03-11 | 31.5 | 2024-01-04 | 26.8 |
| 2024-03-08 | 31.5 | 2024-01-03 | 26.8 |
| 2024-03-07 | 31.5 | 2024-01-02 | 26.8 |
| 2024-03-06 | 31.5 | 2023-12-29 | 26.8 |
| 2024-03-05 | 31.5 | 2023-12-28 | 26.8 |
| 2024-03-04 | 31.5 | 2023-12-27 | 26.4 |
| 2024-03-01 | 31.5 | 2023-12-26 | 26.4 |
| 2024-02-29 | 31.5 | 2023-12-22 | 26.4 |
| 2024-02-28 | 31.5 | 2023-12-21 | 26.4 |
| 2024-02-27 | 31.5 | 2023-12-20 | 26.4 |
| 2024-02-26 | 31.5 | 2023-12-19 | 26.4 |
| 2024-02-23 | 31.5 | 2023-12-18 | 26.4 |
| 2024-02-22 | 31.5 | 2023-12-15 | 26.4 |
ResMed Inc (RSMDF) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
ResMed Inc
NAICS : 339112
SIC : 3841
ISIN : AU000000RMD6
Share Class Description:
RSMDF: CHESS Depositary Interests on a ratio of 10 CDIs per ord.shCompare
Compare
Traded in other countries / regions
RMD.AustraliaRMD.USARMEA.GermanyRMD.MexicoR1MD34.BrazilRMD.Austria0KW4.UK IPO Date
2014-02-04Description
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers